Seeking Alpha

Chembio Diagnostics (CEMI) jumps 3.4% premarket after saying its FDA-approved Clearview COMPLETE...

Chembio Diagnostics (CEMI) jumps 3.4% premarket after saying its FDA-approved Clearview COMPLETE HIV 1/2 assay has received CE Mark approval in Europe. The product will be marketed in the EU under the name SURE CHECK, and CEMI says it expects sales as soon as Q1 2014. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs